The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
 
Jennifer Maria Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Rakuten Medical
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck
 
Voichita Bar Ad
No Relationships to Disclose
 
Emily Lorber
No Relationships to Disclose
 
Dawn Poller
No Relationships to Disclose
 
Gregor Manukian
No Relationships to Disclose
 
Adam Luginbuhl
Research Funding - Bristol-Myers Squibb
 
Joseph M. Curry
Consulting or Advisory Role - Rakuten Medical
Research Funding - AstraZeneca; Castle Biosciences
 
David M. Cognetti
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Rakuten Medical
 
Scott W. Keith
No Relationships to Disclose
 
Rita Susan Axelrod
No Relationships to Disclose
 
Ulrich Rodeck
Stock and Other Ownership Interests - Akriveia Therapeutics; Akriveia Therapeutics
Research Funding - Advaxis; Akrevia Therapeutics; Akrevia Therapeutics; AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Royalties related to several patents
 
Larry Harshyne
No Relationships to Disclose
 
Athanassios Argiris
Consulting or Advisory Role - Aspyrian Therapeutics; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Roche; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono